Treatment fluids for acid stimulation operations and methods related thereto

US12435263B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12435263-B2
Application numberUS-202418664761-A
CountryUS
Kind codeB2
Filing dateMay 15, 2024
Priority dateNov 21, 2023
Publication dateOct 7, 2025
Grant dateOct 7, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Treatment fluids for acid stimulation operations and methods related thereto. Treatment fluids comprise: an aqueous acid solution comprising a mineral acid and an organic acid; and a retardation additive comprising: 1-15 wt % of an oleaginous liquid; 5-30 wt % of a fatty alkyl alcohol ethoxylate; 2-40 wt % of at least one of a fatty alkyl ethoxylated ammonium salt, a zwitterionic surfactant, an alkyl ether sulfate salt, or an alkyl ether sulfonate salt; 4-30 wt % of a co-solvent; and 10-85 wt % of an aqueous fluid, each wt % based on a total mass of the retardation additive. Treatment fluids or retardation additives may be oil-in-water emulsions. Treatment fluids may have 0.5-5 gallons per thousand, based on an overall volume of the treatment fluid of the retardation additive. Methods comprise providing and introducing the treatment fluid into a subterranean formation during a stimulation operation.

First claim

Opening claim text (preview).

What is claimed is: 1. A treatment fluid comprising: an aqueous acid solution comprising a mineral acid and an organic acid; and a retardation additive, wherein the retardation additive comprises: 1 wt % to 15 wt % of an oleaginous liquid; 5 wt % to 30 wt % of a fatty alkyl alcohol ethoxylate; 2 wt % to 40 wt % of at least one of an alkyl ether sulfate salt; 4 wt % to 30 wt % of a co-solvent; and 10 wt % to 85 wt % of an aqueous fluid, each wt % based on a total mass of the retardation additive, and wherein the retardation additive has a volume concentration in the treatment fluid of 0.5 gallons per thousand (gpt) to 5 gpt, based on an overall volume of the treatment fluid, and, wherein the treatment fluid forms an oil-in-water emulsion. 2. The treatment fluid of claim 1 , wherein the mineral acid comprises 10 wt % to 30 wt % hydrochloric acid solution, by total weight of the hydrochloric acid solution, wherein the organic acid comprises methane sulfonic acid, glutamic acid diacetate, or any combination thereof, and wherein the organic acid comprises an organic acid solution with an acid concentration of 10 wt % to 80 wt %, by total weight of the organic acid solution. 3. The treatment fluid of claim 1 , wherein the mineral acid comprises a mineral acid solution and the organic acid comprises an organic acid solution, and wherein the mineral acid solution and the organic acid solution are in a ratio of 9:1 to 1:1, by volume of the solutions. 4. The treatment fluid of claim 1 , wherein the oleaginous liquid comprises a terpene, a hydrocarbon, a fatty acid ester, or any combination thereof. 5. The treatment fluid of claim 1 , wherein the fatty alkyl alcohol ethoxylate comprises a linear or branched C 6 -C 18 alcohol ethoxylate comprising 3 to 30 ethoxylate repeat units. 6. The treatment fluid of claim 1 , wherein the fatty alkyl ethoxylated ammonium salt is present and comprises at least one functionalized alkyl group having 3 to 30 ethoxylate repeat units. 7. The treatment fluid of claim 1 , wherein the zwitterionic surfactant is present and comprises a C 12 -C 18 betaine, a C 12 -C 18 sultaine, or any combination thereof. 8. The treatment fluid of claim 1 , wherein the alkyl ether sulfate salt or the alkyl ether sulfonate salt is present and comprises an ammonium salt. 9. The treatment fluid of claim 1 , wherein the co-solvent comprises an alcohol, a glycol, a glycol ether, a glycol ester, or any combination thereof.

Assignees

Inventors

Classifications

  • by forming crevices or fractures · CPC title

  • Enhanced recovery methods for obtaining hydrocarbons · CPC title

  • containing surfactants · CPC title

  • C09K8/74Primary

    combined with additives added for specific purposes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12435263B2 cover?
Treatment fluids for acid stimulation operations and methods related thereto. Treatment fluids comprise: an aqueous acid solution comprising a mineral acid and an organic acid; and a retardation additive comprising: 1-15 wt % of an oleaginous liquid; 5-30 wt % of a fatty alkyl alcohol ethoxylate; 2-40 wt % of at least one of a fatty alkyl ethoxylated ammonium salt, a zwitterionic surfactant, an…
Who is the assignee on this patent?
Saudi Arabian Oil Co
What technology area does this patent fall under?
Primary CPC classification C09K8/74. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).